SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain

Abstract Background Neuropathic pain is experienced worldwide by patients suffering from nerve injuries, infectious or metabolic diseases or chemotherapy. However, the treatment options are still limited because of low efficacy and sometimes severe side effects. Recently, the deficiency of FKBP51 wa...

Full description

Bibliographic Details

Published in:	Journal of Neuroinflammation
Main Authors:	Saskia Wedel, Praveen Mathoor, Oliver Rauh, Tim Heymann, Cosmin I. Ciotu, Dominik C. Fuhrmann, Michael J. M. Fischer, Andreas Weigert, Natasja de Bruin, Felix Hausch, Gerd Geisslinger, Marco Sisignano
Format:	Article
Language:	English
Published:	BMC 2022-10-01
Subjects:	SAFit2 FKBP51 Neuropathic pain Neuroinflammation Sensory neurons
Online Access:	https://doi.org/10.1186/s12974-022-02615-7